Industry News
Marquette General to Improve Patient Care across Michigan's Upper Peninsula with McKesson EHR
Portola Pharmaceuticals Announces Senior Management and Board Changes
Leading Varian-Equipped Proton Therapy Center Treats 100th Patient
FDA Grants Orphan Drug Status to Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
Hana Biosciences Appoints Craig W. Carlson as Chief Financial Officer
Agilent Technologies' Fault Detective Test Optimization and Diagnostic Software Delivers Results up to 1,000 Times Faster
Nutracea Completes Sale Of Non-Core Cereal Ingredients Business
Codexis Names Vonnie Estes To New Technology Strategic Planning VP Role
Cancer Patients in Kent Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian
Peer-Reviewed Published Study Demonstrates Safety of UC-II
Duquesne University, Agilent Technologies Establish Mass Spectrometry Center of Excellence to Study Diseases, Environmental Issues
Vermillion Announces Scientific Advisory Board Appointments
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis
Odyssey Thera announces agreement with Lonza
Biosearch Technologies Expands Licensing of Roche Patents to Manufacture Kits Targeting the in-vitro Diagnostic Industry
Concentric Medical and the Merci Retrieval System Highlighted at the 2010 International Stroke Conference
Ingenuity Systems Announces New Distributor in Taiwan
BioImagene Introduces the iSlide to Enhance the Transition from Manual to Digital Pathology
Solazyme and Unilever Partner to Bring Algal Renewable Oil to Personal Care Products
Newly Published Data Shows Chronix Biomedical's Serum Dna Assays Can Detect Early-Stage Breast Cancer
Bruker and Agilent Technologies Announce Agreement for Bruker to Acquire Certain Varian Inc. Product Lines
Trading Halted in InterMune Common Stock
FDA Advisory Committee Recommends Approval of InterMune's Esbriet (pirfenidone) for Idiopathic Pulmonary Fibrosis
OVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for Ovarian Cancer
Entelos and RegeneMed Introduce iToxFX to Help Predict the Safety of New Drugs
Bayer CropScience and Mendel Biotechnology expand collaboration in crop protection
Fluidigm Releases 5KB & 10KB Long Range PCR Protocol Access Array Systems
Patrick Pichette Joins Amyris Board of Directors
Varian Medical Systems Names Dr. John Adler as Chief of New Clinical Applications
VIVUS Announces the Issuances of Three Additional Qnexa Patents
Nektar Announces Positive Phase II Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer
Exelixis Announces Restructuring
Genomic Health Announces Publication of Study Using Oncotype DX in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
McKesson Named "Most Admired" Company Among Healthcare Distributors by FORTUNE Magazine and one of Nation's 100 Best Corporate Citizens by Corporate Responsibility Magazine
Next Generation Dissolution Apparatus From Varian, Inc. Blends Flexibility With Automation
InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
XenoPort Restructures to Focus on Key Programs
Tecan and ForteBio automate label-free assays for bioprocess and drug discovery applications
BioImagene Supports University of Miami's Relief Program in Haiti with Digital Pathology Solutions
Varian Medical Systems to Highlight Leading Solutions for Digital X-Ray Imaging at the ECR Annual Meeting
bioTheranostics Announces Commercial Availability of Expanded Tumor-Type Database for CancerTYPE ID and the Launch of KRAS Testing